AtriCure (ATRC) holder Hood River reports 6.23% stake
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Hood River Capital Management LLC filed Amendment No. 2 to a Schedule 13G reporting its beneficial ownership of AtriCure, Inc. common stock. The firm reports holding 3,096,611 shares, representing 6.23% of the outstanding common stock as of the event date.
Hood River discloses sole power to dispose of these 3,096,611 shares but no power to vote them. It certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of AtriCure.
Positive
- None.
Negative
- None.
FAQ
What stake in AtriCure (ATRC) does Hood River Capital report on this Schedule 13G/A?
Hood River Capital Management LLC reports beneficial ownership of 3,096,611 AtriCure common shares, representing 6.23% of the class. This stake reflects its economic interest in AtriCure stock as of the reported event date, without implying any change in corporate control intentions.
What type of SEC filing is this for AtriCure (ATRC) and what does Amendment No. 2 mean?
This is an Amendment No. 2 to a Schedule 13G, which updates a passive ownership report for AtriCure common stock. It revises prior disclosures to reflect Hood River Capital’s current beneficial ownership and related powers as of the stated event date, 12/31/2025.
Who signed the AtriCure (ATRC) Schedule 13G/A on behalf of Hood River Capital?
The Schedule 13G/A is signed by Robert Schmaltz, identified as CCO and COO. His signature certifies, after reasonable inquiry, that the information in the statement regarding Hood River Capital’s AtriCure holdings is true, complete, and correct as of the date signed.